SDS Optic
Latest round
- Series A
Last raised
- Jan 2018
Total raised
- $2.8M
Investors
- 1
About SDS Optic
A. operates as a biotechnology research and development company that offers healthcare solutions for patients and doctors. The company was Co-founded by Magdalena Staniszewska and Marcin Staniszewski (CEO).A. The company offers medical devices, and optoelectronics, and offers biotechnology research and development services. The medical devices offered by the firm include inProbe which links targeted therapies with targeted diagnostics and the technology used decreases diagnosis time, increases precision, and improves the effects of innovative cancer treatments. The firm also offers SDS optics which helps in the modelling and designing of components, such as ferrules, housings, and other devices with flat and conical surface areas.
Who invested in SDS Optic
1 investor across 1 round
See all investors in SDS Optic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 1, 2018
Amount
$2.8M
Investors
Questions about SDS Optic
Who invested in SDS Optic?
SDS Optic has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SDS Optic raised?
SDS Optic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SDS Optic last raise money?
SDS Optic's most recent round on record is a Series A, in Jan 2018.
What does SDS Optic do?
SDS Optic is a biotechnology company.
Where is SDS Optic headquartered?
SDS Optic is headquartered in Lublin, Poland.
Which VCs invest in companies like SDS Optic?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at SDS Optic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SDS Optic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.